Asymptomatic Inflammatory Bowel Disease in Catalonia

NCT04794465 | Unknown

• 1 other identifier: 2021/5006
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

An early treatment of inflammatory bowel disease (IBD) has been proposed to correlate to better outcomes. In Catalonia the screening programme was implemented in all the territory in 2015. The aim of this study is to describe the natural history of the asymptomatic IBD detected during colorectal cancer population screening.

Conditions

Inflammatory Bowel Diseases

Keywords

inflammatory bowel disease; epidemiology

Outcome Measures

Primary Outcomes (1)

• Time to treatment

  To see the evolution of the asymptomatic IBD and the need for the treatment

  From date of diagnosis until the date of first treatment, assessed up to 19 years.

Secondary Outcomes (1)

• Time to symptoms

  From date of diagnosis until the date of first symptom, assessed up to 19 years.

Study Arms (1)

Asymptomatic IBD diagnosed during the colorectal cancer screening

Diagnostic Test: Colorectal cancer screening

Interventions

Colorectal cancer screening DIAGNOSTIC_TEST

Patients with IBP diagnosed during the colorectal cancer screening

Asymptomatic IBD diagnosed during the colorectal cancer screening

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Centre selection and recruitment: All the participating centres in population colorectal cancer screening in Catalonia will be invited. All the participating centres must certify the approval of the protocol in their ethical committees. Study population: All patients with asymptomatic IBD diagnosed during the population colorectal cancer screening in the Catalonian colorectal screening program within the period 2000 to 2019 will be included.

You may qualify if:

• All patients with asymptomatic IBD diagnosed during the population colorectal cancer screening in the Catalonian colorectal screening program within the period 2000 to 2019 will be included.

You may not qualify if:

• Symptoms in the first outpatient visit.

Sponsors & Collaborators

• Corporacion Parc Tauli: lead

Study Sites (1)

Corporació Sanitària Parc Taulí

Sabadell, Barcelona, 08208, Spain

Location

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 15 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Epidemiology and Cancer Screening, Corporació Sanitària Parc Taulí, Sabadell, Spain

Study Record Dates

• First Submitted: March 7, 2021
• First Posted: March 12, 2021
• Study Start: April 1, 2021
• Primary Completion: July 15, 2021
• Study Completion: October 31, 2021
• Last Updated: March 12, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)